Skip to main content
ANVS
NYSE Life Sciences

FDA Backs Pooling Alzheimer's and Parkinson's Safety Data for Buntanetap NDA

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.756
Mkt Cap
$46.418M
52W Low
$0.616
52W High
$5.5
52W Position info
23% above low
Off High info
86% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ANVS sits 23% above its 52-week low of $0.616.

Summary

FDA agreed to Annovis's plan to pool safety data from its Alzheimer's and Parkinson's programs into a single Integrated Summary of Safety supporting the buntanetap NDA. The pooled database will span three randomized, placebo-controlled trials plus one open-label extension, with more than 1,600 participants expected to have received the drug by the DUET-AD 6-month readout. This lets the company build the safety package now while DUET-AD and the OLE PD study are still running, rather than waiting for each program to finish. It is a procedural win, not an efficacy result — FDA's agreement does not mean the NDA will be filed, accepted, or approved, and the submission still hinges on DUET-AD efficacy and safety data. The company had $2.8 million of cash at September 30 and a going-concern warning, with the $21.0 million November offering funding operations from here, so the timeline to the DUET-AD readout is the binding constraint.

At the time of this announcement, ANVS was trading at $0.76 on NYSE in the Life Sciences sector, with a market capitalization of approximately $46.4M. The 52-week trading range was $0.62 to $5.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ANVS - Latest Insights

ANVS
Nov 17, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.800
Real-time Price: $0.760 info
Change: -$0.040 (-5%) info
Market Cap: $46.418M info
ANVS
Nov 13, 2026, 4:24 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.940
Real-time Price: $0.760 info
Change: -$0.180 (-19%) info
Market Cap: $46.418M info
ANVS
Nov 06, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.8799
Real-time Price: $0.760 info
Change: -$0.1199 (-14%) info
Market Cap: $46.418M info
ANVS
Nov 05, 2026, 8:05 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.8689
Real-time Price: $0.760 info
Change: -$0.1089 (-13%) info
Market Cap: $46.418M info
ANVS
Nov 04, 2026, 5:01 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $0.760 info
Change: -$0.180 (-19%) info
Market Cap: $46.418M info